Order by 12pm AEDT, Monday to Friday, for same-day shipping!
Order by 12pm AEDT, Monday to Friday, for same-day shipping!
$110.00
6 in stock (can be backordered)
By Buying
3 Bottles
You can get 10% off
By Buying
6 Bottles
You can get 15% off
By Buying
9 Bottles
You can get 20% off
To get a discount, simply add products to the cart and continue to the checkout page, and the discount will automatically be applied.
| Peptide Name | PT-141 (Bremelanotide) |
| Peptide Class | Melanocortin receptor agonist |
| Primary Targets | MC3R and MC4R receptors |
| Mechanism of Action | Central nervous system melanocortin signalling |
| Form | Lyophilised synthetic peptide (must be reconstituted) |
| Research Vial Format | 10 mg |
| Country of Origin | Australia |
| Storage | Lyophilised: store cold and protected from light; Reconstituted: 2–8°C |
| Standard | Research Grade Purity ≥98 percent |
| Peptide Name | PT-141 (Bremelanotide) |
| Peptide Class | Melanocortin receptor agonist |
| Primary Targets | MC3R and MC4R receptors |
| Mechanism of Action | Central nervous system melanocortin signalling |
| Form | Lyophilised synthetic peptide (must be reconstituted) |
| Research Vial Format | 10 mg |
| Country of Origin | Australia |
| Storage | Lyophilised: store cold and protected from light; Reconstituted: 2–8°C |
| Standard | Research Grade Purity ≥98 percent |
[contact-form-7 id=”4c79b99″ title=”SARMS Certificate”]
PT-141, also known as Bremelanotide, is a synthetic peptide derived from α-melanocyte-stimulating hormone (α-MSH) and studied for its effects on sexual arousal, desire, and central nervous system signalling. Unlike phosphodiesterase inhibitors, PT-141 acts primarily through the central melanocortin receptor system, rather than directly affecting peripheral blood flow. PT-141 has been investigated in both male and female research models for conditions involving hypoactive sexual desire, erectile dysfunction, and altered sexual motivation. Its mechanism involves activation of melanocortin receptors (MC3R and MC4R) in the brain, which are associated with sexual behaviour, mood, and reward pathways. Due to this central mode of action, PT-141 is often studied as a distinct alternative to vasodilatory compounds in sexual health research.
| Peptide Name | PT-141 (Bremelanotide) |
| Peptide Class | Melanocortin receptor agonist |
| Primary Targets | MC3R and MC4R receptors |
| Mechanism of Action | Central nervous system melanocortin signalling |
| Form | Lyophilised synthetic peptide (must be reconstituted) |
| Research Vial Format | 10 mg |
| Country of Origin | Australia |
| Storage | Lyophilised: store cold and protected from light; Reconstituted: 2–8°C |
| Standard | Research Grade Purity ≥98 percent |
PT-141 has been evaluated in controlled clinical and preclinical studies examining sexual function and neurobehavioural responses.
Disclaimer: PT-141 is supplied strictly for laboratory research purposes. It is not intended for human consumption or therapeutic use.
PT-141 is studied for sexual arousal, libido regulation, and central nervous system signalling related to sexual behaviour.
PT-141 acts centrally through melanocortin receptors in the brain, while PDE5 inhibitors act peripherally by increasing blood flow.
Yes. Research includes both male and female models, particularly in studies of sexual desire and arousal.
Some studies report transient effects such as nausea or changes in blood pressure, which are monitored in clinical research settings.
No. PT-141 is supplied for research purposes only and is not approved for general human consumption.
| Weight | 0.02 kg |
|---|
